The health insurer plans to channel the proceeds from the divestiture into general corporate operations. While the company expects the sale to finalize during the third quarter of this year, it has explicitly signaled that the move will not materially alter its 2026 financial projections. Specific financial mechanics behind the agreement remain private.

Investors reacted with caution to the announcement, with Humana shares sliding 1.2% to $360.00 during after-hours trading. This exit marks a shift for the insurer as it looks to shed its secondary holdings in the specialized care sector.